Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 590 across all filing types
Latest filing 2012-03-20 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
Princess Margaret Hospital selects RayStation® For Adaptive radiation Therapy
Regulatory Filings Classification · 95% confidence The document is titled "PRESS RELEASE" and details a contract award between RaySearch Laboratories AB and Princess Margaret Hospital (PMH) for the RayStation® treatment planning system. It discusses a business development/sales achievement rather than routine financial reporting (like 10-K, IR, ER) or shareholder actions (like AGM, DIV, DVA). This type of announcement, which is a general business update or news release, does not fit neatly into the specific financial filing categories provided (10-K, IR, ER, CAP, etc.). Therefore, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous corporate announcements that are not otherwise classified.
2012-03-20 English
Advanced Swiss Clinic Selects RayStation®
Regulatory Filings Classification · 97% confidence The document is a press release announcing a specific business event: a contract win where a Swiss clinic selected RaySearch Laboratories' RayStation® treatment planning system. This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It details a significant commercial transaction and partnership. Since there is no specific category for 'Business Contract Announcement' or 'Sales Win', and it is a general announcement about company activity that doesn't fit the other specific financial or governance codes (like DIV, CAP, MANG, DIRS), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for non-standard regulatory or material news releases.
2012-03-15 English
Avancerad scweizisk klinik väljer RayStation®
Regulatory Filings Classification · 95% confidence The document is a press release dated March 15, 2012, announcing a new order for the RayStation® dose planning system from a Swiss hospital. It details the product features, quotes management, and provides company background. This type of announcement, which is a specific business development update (a new contract/sale) rather than a mandatory regulatory filing (like 10-K, ER, or DIV), fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, or potentially 'Capital/Financing Update' (CAP) if the order represented significant revenue, but RNS is the most appropriate fallback for general news releases that aren't explicitly defined elsewhere. Given the options, it is a general corporate announcement/news release.
2012-03-15 Swedish
Leading German Cancer center Selects RayStation®
Regulatory Filings Classification · 97% confidence The document is a press release dated March 7, 2012, announcing that the German Cancer Research Center (DKFZ) has placed an order for RaySearch Laboratories' RayStation® treatment planning system. This announcement details a significant business transaction (an order/sale) but does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, or DIV). It is a general business update concerning a major customer acquisition/contract. Since it is not a formal regulatory filing (like a 10-K or 8-K equivalent mentioned in the definitions) and doesn't fit the other specific categories (like M&A, Capital Change, or Director Dealing), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for miscellaneous corporate news that doesn't fit elsewhere, although it is primarily a press release announcing a sale.
2012-03-07 English
Ledande tyskt cancercenter väljer RayStation®
Regulatory Filings Classification · 95% confidence The document is a press release dated March 7, 2012, announcing that RaySearch Laboratories AB has received an order for its RayStation® dose planning system from the German Cancer Research Center (DKFZ). The content focuses on a specific business transaction (a new order/sale) and provides details about the customer and the product. This type of announcement, detailing a significant business event or contract win, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a general corporate announcement regarding business operations and sales success. Given the available options, the most appropriate classification is 'Regulatory Filings' (RNS) as a general regulatory announcement or press release that doesn't match a more specific category like M&A (TAR) or Capital Change (CAP). Since it is a press release announcing a specific business event (a major order), and RNS is the fallback for general regulatory announcements, RNS is the best fit.
2012-03-07 Swedish
James E. Cary Cancer Center selects RayStation®
Regulatory Filings Classification · 95% confidence The document is a press release dated February 20, 2012, announcing that the James E. Cary Cancer Center has selected RaySearch Laboratories' RayStation® treatment planning system. This is a specific business announcement regarding a contract win and product adoption, not a mandatory regulatory filing like a 10-K, an earnings release, or a dividend notice. It does not fit the definitions for AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a specific, non-standard announcement that doesn't fit the primary categories, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory or significant corporate announcements that aren't covered elsewhere.
2012-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.